Reckitt Benckiser CEO says acquisitions to strengthen health portfolio would be considered
Reckitt Benckiser [LON:RB] chief executive Rakesh Kapoor said the UK-based consumer products company would look at acquisitions that would bolster its health products portfolio, the Financial Times reported.
Kapoor, quoted in a report about Reckitt’s FY15 results, said that if the company can derive more value from a brand that is available, it will consider making an acquisition.
Reckitt’s consumer health arm’s growth rate - in the double digits - is unsustainable, Kapoor said.
Reckitt Benckiser’s FY15 results showed a 5% increase in net revenue to GBP 8.87bn and an adjusted operating profit of GBP 2.24bn, up 4%.
Background:
Kapoor, quoted in an Irish Independent report on 7 December 2015, confirmed that Reckitt was interested in Pfizer’s [NYSE:PFE] consumer health business.
A market report in The Daily Mail on 3 February said Reckitt was believed to be the leading contender to acquire GlaxoSmithKline’s [LON:GSK] consumer health business, but did not cite a source for the speculation.